Latest Schedule 13G passive stakes

Barclays PLC has disclosed a beneficial ownership of 6.99% in Oaktree Acquisition Corp I-A's common stock as of June 30, 2026.

Barclays PLC has disclosed beneficial ownership of 6.81% of CH4 Natural Solutions' common stock as of June 30, 2026.

Barclays PLC has disclosed beneficial ownership of 6.81% of CH4 Natural Solutions' common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting a beneficial ownership of 6.30% in Liberty Broadband-A common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting a beneficial ownership of 6.30% in Liberty Broadband-A common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 5.99% of Cartesian Therapeutics Inc. common stock as of June 30, 2026.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 5.99% of Cartesian Therapeutics Inc. common stock as of June 30, 2026.

GIC Private Limited has reported a beneficial ownership of 7.43% in MakeMyTrip Limited, holding 6,719,113 ordinary shares.

Jay Edelberg has reported beneficial ownership of 4,878,105 shares, representing 5.2% of Kardigan, Inc.'s common stock, as of June 30, 2026.

GIC Private Limited, along with its subsidiaries GIC Special Investments Private Limited and Ceningan Investment Pte. Ltd., has reported increased beneficial ownership in GDS Holdings Limited, primarily through convertible notes.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 8.43% of Office Properties Income REIT.

Barclays PLC has filed a Schedule 13G, reporting beneficial ownership of 8.43% of Office Properties Income REIT.

Barclays PLC has disclosed beneficial ownership of 7.84% of Forward Air Corp's common stock as of June 30, 2026.

Barclays PLC has disclosed beneficial ownership of 7.84% of Forward Air Corp's common stock as of June 30, 2026.

Barclays PLC has disclosed beneficial ownership of 7.00% of ProCap Acquisition Corp's common stock, holding 1,780,100 shares.

Barclays PLC has disclosed beneficial ownership of 7.00% of ProCap Acquisition Corp's common stock, holding 1,780,100 shares.

Group One Trading LLC has disclosed beneficial ownership of 1,000,368 shares, representing 5.0% of Cato Corp's Class A Common Stock, as of June 30, 2026.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed a Schedule 13G amendment indicating their beneficial ownership of Wolfspeed, Inc. common stock has fallen below the 5% reporting threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed a Schedule 13G amendment indicating their beneficial ownership of Wolfspeed, Inc. common stock has fallen below the 5% reporting threshold.

Honeywell International Inc. and its subsidiary Honeywell Holdings International Inc. report a combined beneficial ownership of 79.1% of Quantinuum Inc.'s Class A Common Stock as of June 30, 2026.

Honeywell International Inc. and its subsidiary Honeywell Holdings International Inc. report a combined beneficial ownership of 79.1% of Quantinuum Inc.'s Class A Common Stock as of June 30, 2026.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, disclosing beneficial ownership of 5.2% of Voya Asia Pacific High Dividend Equity Income Fund's common shares.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, disclosing beneficial ownership of 5.2% of Voya Asia Pacific High Dividend Equity Income Fund's common shares.

Millennium Management LLC, along with affiliated entities, has reported beneficial ownership of 5.1% of Ralliant Corporation's common stock.

Group One Trading LLC has reported beneficial ownership of 9,445,376 shares, representing 5.5% of the outstanding common stock of POET Technologies Inc. as of June 30, 2026.

Morgan Stanley and its subsidiary report beneficial ownership of 8.0% of Virtus Convertible & Income Fund II's 5.50% Series A Cumulative Preferred Shares.

Morgan Stanley and its subsidiary report beneficial ownership of 8.0% of Virtus Convertible & Income Fund II's 5.50% Series A Cumulative Preferred Shares.

Morgan Stanley has disclosed beneficial ownership of 6.1% of Terawulf Inc.'s common stock as of June 30, 2026.

Morgan Stanley has disclosed beneficial ownership of 6.1% of Terawulf Inc.'s common stock as of June 30, 2026.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amended Schedule 13G, reporting a combined beneficial ownership of 5.1% in Taysha Gene Therapies, Inc.